Page 4 - Junjie Zhang News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Junjie zhang. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Junjie Zhang Today - Breaking & Trending Today

Texas A&M AgriLife receives grant to support research on bacteriophage therapy


Texas A&M AgriLife receives grant to support research on bacteriophage therapy
The National Institute of Allergy and Infectious Diseases, NIAID, part of the National Institutes of Health, NIH, has awarded $2.5 million in grants to support research on bacteriophage therapy, and Texas A&M AgriLife Research is among the grant recipients.
Woman, Dr. Lanying Zeng, sitting in a chair at a desk in her laboratory where she is conducting a study with phages.
Lanying Zeng, Ph.D., is one of the principal investigators for the new NIH-funded phages study focusing on pili suppression. (Texas A&M AgriLife photo by Laura McKenzie) Bacteriophage therapy is an emerging field that many researchers think could yield novel ways to fight antimicrobial-resistant bacteria. A Centers for Disease Control and Prevention report from 2019 showed antibiotic-resistant pathogens cause more than 2.8 million infections and more than 35,000 deaths annually in the U.S. ....

United States , Lanying Zeng , Junjie Zhang , Emily Henderson , Centers For Disease , Texasam University , National Institute Of Allergy , National Institutes Of Health , Texasam Agrilife Research , Department Of Biochemistry , Phage Technology , Agrilife Research , Proceedings Of The National Academy Sciences , National Institute , Infectious Diseases , National Institutes , Laura Mckenzie , Disease Control , Agrilife Research Led , National Academy , Associate Professor , ஒன்றுபட்டது மாநிலங்களில் , எமிலி ஹென்டர்சன் , மையங்கள் க்கு நோய் , தேசிய நிறுவனம் ஆஃப் ஒவ்வாமை , தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம் ,

Texas A&M agrilife research investigating phages to fight bacterial infection


 E-Mail
The National Institute of Allergy and Infectious Diseases, NIAID, part of the National Institutes of Health, NIH, has awarded $2.5 million in grants to support research on bacteriophage therapy, and Texas A&M AgriLife Research is among the grant recipients.
Woman, Dr. Lanying Zeng, sitting in a chair at a desk in her laboratory where she is conducting a study with phages.
Lanying Zeng, Ph.D., is one of the principal investigators for the new NIH-funded phages study focusing on pili suppression. (Texas A&M AgriLife photo by Laura McKenzie)
Bacteriophage therapy is an emerging field that many researchers think could yield novel ways to fight antimicrobial-resistant bacteria. A Centers for Disease Control and Prevention report from 2019 showed antibiotic-resistant pathogens cause more than 2.8 million infections and more than 35,000 deaths annually in the U.S. ....

United States , Paul Schattenberg , Lanying Zeng , Junjie Zhang , Laura Mckenzie , Centers For Disease , Texasam University , National Institute Of Allergy , National Institutes Of Health , Texasam Agrilife Research , Department Of Biochemistry , Phage Technology , Agrilife Research , Proceedings Of The National Academy Sciences , National Institute , Infectious Diseases , National Institutes , Disease Control , Agrilife Research Led , National Academy , ஒன்றுபட்டது மாநிலங்களில் , லாரா மகெந்ஸீ , மையங்கள் க்கு நோய் , தேசிய நிறுவனம் ஆஃப் ஒவ்வாமை , தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம் , துறை ஆஃப் உயிர் வேதியியல் ,

Bacteriophage therapy: NIH awards $2.5 million in grants to support research


The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded $2.5 million in grants to 12 institutes around the world to support research on bacteriophage therapy. These awards represent NIAID’s first series of grants focused exclusively on research on this therapy, an emerging field that could yield new ways to fight antimicrobial-resistant bacteria. A 2019 report from CDC found that antibiotic-resistant pathogens cause more than 2.8 million infections in the U.S. each year and more than 35,000 people die.
A computer-generated rendition of a bacteriophage.
Image/NIAID
Bacteriophages (or “phages”) are viruses that can kill or incapacitate specific kinds of bacteria while leaving other bacteria and human cells unharmed. By gathering naturally-occurring phages, or by modifying or engineering phages to display certain properties, researchers hope to create novel anti-bacterial therapeutics. Because phages ....

New York , United States , Lanying Zeng , Yoann Stephane Le Breton , Ericj Rubin , Grahamf Hatfull , Andrew Camilli , Anthonys Fauci , Asma Hatoum , John Joseph Dennehy , Samuel Paul Brown , Srivatsan Raman , Terje Dokland , Ian Fleming , Simon White , Junjie Zhang , Queens College , University Of Pittsburgh At , Harvard School Of Public Health Boston , National Institute Of Allergy , National Institutes Of Health , Georgia Institute Of Technology Atlanta , University Of Alabama At Birmingham , City University Of New York , University Of Wisconsin , Geneva Foundation Tacoma ,